Foundations of Care and Comprehensive Medical Evaluation: Difference between revisions

	2016 ADA Guideline Recommendations
Types of Diabetes Mellitus
Main Diabetes Page
Diabetes type I
Diabetes type II
Gestational Diabetes Mellitus
2016 ADA Standard of Medical Care Guideline Recommendations
Strategies for Improving Care
Classification and Diagnosis of Diabetes
Foundations of Care and Comprehensive Medical Evaluation Diabetes Self-Management, Education, and Support Nutritional Therapy
Prevention or Delay of Type II Diabetes
Glycemic Targets
Obesity Management for Treatment of Type II Diabetes
Approaches to Glycemic Treatment
Cardiovascular Disease and Risk Management Hypertension and Blood Pressure Control Lipid Management Antiplatelet Agents Coronary Heart Disease
Microvascular Complications and Foot Care Diabetic Kidney Disease Diabetic Retinopathy Diabetic Neuropathy Diabetic Footcare
Older Adults with Diabetes
Children and Adolescents with Diabetes Management of Cardiovascular Risk Factors in Children and Adolescents with Diabetes Microvascular Complications in Children and Adolescents with Diabetes
Management of Diabetes in Pregnancy
Diabetes Care in the Hospital Setting

Revision as of 15:54, 7 December 2016

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shivani Chaparala M.B.B.S [2]; Seyedmahdi Pahlavani, M.D. [3]; Tarek Nafee, M.D. [4]

"1. Children with diabetes or predia- betes should be encouraged to en- gage in at least 60 min of physical activity each day. (Level of Evidence: B)"
"2. Adults with diabetes should be ad- vised to perform at least 150 min/ week of moderate-intensity aerobic physical activity (50–70% of maxi- mum heart rate), spread over at least 3 days/week with no more than 2 consecutive days without exercise. (Level of Evidence: A)"
"3. All individuals, including those with diabetes, should be encouraged to reduce sedentary time, particularly by breaking up extended amounts of time (.90 min) spent sitting. (Level of Evidence: B)"
"4. In the absence of contraindications, adults with type 2 diabetes should be encouraged to perform resistance training at least twice per week. (Level of Evidence: A)"

"1. Advise all patients not to use ciga- rettes, other tobacco products, or e-cigarettes. (Level of Evidence: A)"
"2.Include smoking cessation coun- seling and other forms of treat- ment as a routine component of diabetes care. (Level of Evidence: B)"

"1. Provide routine vaccinations for children and adults with diabetes as for the general population ac- cording to age-related recommendations (Level of Evidence: C)"
"2.Administer hepatitis B vaccine to unvaccinated adults with diabetes who are aged 19–59 years. (Level of Evidence: C)"
"3. Consider administering hepatitis B vaccine to unvaccinated adults with diabetes who are aged >60 years. (Level of Evidence: C)"

"1. The patient’s psychological and social situation should be ad- dressed in the medical manage- ment of diabetes. (Level of Evidence: B)"
"2. Psychosocial screening and follow- up may include, but are not lim- ited to, attitudes about the illness, expectations for medical man- agement and outcomes, affect/ mood, general and diabetes-related quality of life, resources (financial, social, and emotional), and psychiatric history. (Level of Evidence: E)"
"3.Routinely screen for psychoso- cial problems such as depression, diabetes-related distress, anxiety, eating disorders, and cognitive impairment. (Level of Evidence: B)"
"4. Older adults (aged $65 years) with diabetes should be consid- ered for evaluation of cognitive function and depression screening and treatment. (Level of Evidence: B)"
"5. Patients with comorbid diabetes and depression should receive a stepwise collaborative care ap- proach for the management of depression (Level of Evidence: A)"

A complete medical evaluation should be performed at the initial visit to

"1. Confirm the diagnosis and classify diabetes (Level of Evidence: B)"
"2. Detect diabetes complications and potential comorbid conditions. (Level of Evidence: E)"
"3.Review previous treatment and risk factor control in patients with established diabetes (Level of Evidence: E)"
"4. Begin patient engagement in the formulation of a care manage- ment plan. (Level of Evidence: B)"
"5. Develop a plan for continuing care (Level of Evidence: B)"

@@ Line 31: / Line 31: @@
 | bgcolor="Seashell"|<nowiki>"</nowiki>'''2.'''Administer hepatitis B vaccine to unvaccinated adults with diabetes who are aged 19–59 years. ''([[American Diabetes Association#Evidence Grading System|Level of Evidence: C]])''<nowiki>"</nowiki>
 |-
-| bgcolor="Seashell"|<nowiki>"</nowiki>'''3.''' Consider administering hepatitis B vaccine to unvaccinated adults with diabetes who are aged $60 years. ''([[American Diabetes Association#Evidence Grading System|Level of Evidence: C]])''<nowiki>"</nowiki>
+| bgcolor="Seashell"|<nowiki>"</nowiki>'''3.''' Consider administering hepatitis B vaccine to unvaccinated adults with diabetes who are aged >60 years. ''([[American Diabetes Association#Evidence Grading System|Level of Evidence: C]])''<nowiki>"</nowiki>
-|-
-| bgcolor="Seashell"|<nowiki>"</nowiki>'''4.''' If a second-generation antipsychotic medication is prescribed, changes in weight, glycemic control, and cho- lesterol levels should be carefully monitored and the treatment regi- men should be reassessed. ''([[American Diabetes Association#Evidence Grading System|Level of Evidence: C]])''<nowiki>"</nowiki>
 |-
 |}